Study of karanj malahar in management of kapaja yonivyapad

Randomised open control study of karanj malahar in management of kapaja yonivyapad

Status

Active, not recruiting

Phases

Phase 1Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2019/10/021772

Enrollment

Registered

2019-10-23

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N898- Other specified noninflammatory disorders of vagina Health Condition 2: N898- Other specified noninflammatory disorders of vagina

Interventions

Intervention1: karanj malahar: per vaginal application of karanj malahar for 7 days Control Intervention1: karanja malahar: per vaginal application of karanj malahar Control Intervention2: clotrimazol

Eligibility

Inclusion criteria

Inclusion criteria: marrisd non pregnant women with regular menstrual cycle having yonigatshwetstrav, yonikandu, alpavedana, gandha.

Exclusion criteria

Exclusion criteria: diabetic unmarried pregnant women having STD,Ca,post menopausal condition,cervical erosion,local skin lesion.

Design outcomes

Primary

Measure	Time frame
to study the efficacy of karanj malahar in kaphaj yonivyapadTimepoint: 18 months	—

Secondary

Measure	Time frame
to study the mode of action of karanja malaharTimepoint: 7 days	—

Countries

India, Zimbabwe

Contacts

Public ContactDr Milind Hirve

Annasaheb Dange Ayurved Medical college Ashta

drmilindhirave@gmail.com9860582881

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026